Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New report highlights impact of intellectual property on U.S. economy

By Mark Grayson  |    October 13, 2016
In late September, the U.S. Department of Commerce released a comprehensive report that found intellectual property (IP) intensive industries contribute more than $6 trillion (38.2 percent) to U.S....   Read More

Nearly 4.5 million jobs and counting

By Priscilla VanderVeer  |    May 17, 2016
At PhRMA, we have the honor of highlighting the hope that America’s biopharmaceutical companies bring to patients in the form of innovative treatments and cures. But beyond the value that medicines...   Read More

PhRMA member companies invested $58.8 billion in R&D in 2015

By Stephen J. Ubl  |    May 12, 2016
For more than 30 years, the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, driving innovation for patients. And PhRMA member companies continue to be...   Read More

A new kind of Chart Pack

By Christian Clymer  |    October 15, 2015
I’m excited to introduce our new online Chart Pack, a resource designed to visually demonstrate how much value America’s biopharmaceutical researchers and manufacturers bring to our nation’s broader...   Read More

From Hope to Cures: The Value of Biopharmaceutical Innovation

By Ieva M. Augstums  |    August 20, 2015
Biopharmaceutical innovation means more than helping patients lead longer, healthier, more productive lives. Through the continued development of new treatments and cures, each discovery contributes...   Read More

Biopharmaceutical Innovation Benefits Many Sectors of Industry

By PhRMA Staff  |    July 8, 2015
While the connection between sectors isn’t obvious to many, the sheet metal industry plays an integral role in the development of new medicines. Without it, many innovative new treatment options...   Read More

PhRMA Member Companies Invested $51.2 Billion in R&D in 2014

By John Castellani  |    April 20, 2015
Earlier today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced that its member companies have invested more than $600 billion in the search for new treatments and cures...   Read More

A Life-Saving Life’s Work: A Story on the Impact of Clinical Trials

By Guest Contributor  |    March 23, 2015
Clinical trials are an essential step in the process to develop new medicines and as they work to bring about lifesaving new treatments, they also contribute to the local economies where they are...   Read More

Biopharmaceutical Industry Leads Manufacturing Sector in R&D Spending

By Mark Grayson  |    March 23, 2015
The biopharmaceutical industry comes out on top as the country’s manufacturing leader in innovation and economic contributions in a new report from ndp | analytics. According to the analysis, the...   Read More

New Report: Clinical Trials and the Impact on State Economies

By John Corea  |    March 12, 2015
Beyond the profound value that biopharmaceutical industry research and development (R&D) brings patients – new treatments and potential cures for society’s most devastating and costly diseases – are...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates